TrialBMC infectious diseases2017

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study.

Tim R Cressey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.